Dr. Jeffrey Tobias, chief medical officer of pain drug developer NeurogesX Inc. since 2005, will resign effective Oct. 16
It is the second high-level departure this year for San Mateo-based NeurogesX (NASDAQ: NGSX). President and CEO Anthony DiTonno said in April that he would retire by the end of the year.
No comments:
Post a Comment